On Thursday, September 17, Natasha Sheybani, PhD, introduced the concept of gene therapy and explained how focused ultrasound technology is poised to play a role in this exciting field. She reviewed the strengths and weaknesses of gene therapy and provided an overview of preclinical applications in the field to demonstrate the utility of focused ultrasound-mediated gene therapy across a range of diseases and conditions.
Natasha Sheybani, PhD
Postdoctoral Research Fellow, Stanford University
Focused Ultrasound for Gene Therapy:
About the Speaker
Dr. Natasha Sheybani is a Postdoctoral Research Fellow at Stanford University, where her appointment is shared among the Departments of Oncology, Radiology, and Biomedical Data Science. Her research focuses on advancing machine learning-based radiogenomics for precision oncology.
Dr. Sheybani received her BS (2015) and PhD (2020) in Biomedical Engineering from Virginia Commonwealth University and University of Virginia (UVA), respectively.
Her graduate research at UVA centered on leveraging image-guided focused ultrasound to potentiate immunotherapy for primary and disseminated solid cancers. During her training, Dr. Sheybani was supported by the NSF Graduate Research Fellowship and Robert R. Wagner Fellowship, and she currently holds the prestigious NCI F99/K00 Predoctoral to Postdoctoral Fellow Transition Award.